+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
AI in Cancer Diagnostics Market by Application, Component, End User, Cancer Type, Technology - Global Forecast to 2030- Product Image
AI in Cancer Diagnostics Market by Application, Component, End User, Cancer Type, Technology - Global Forecast to 2030- Product Image
Sale

AI in Cancer Diagnostics Market by Application, Component, End User, Cancer Type, Technology - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5716125
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

AI in cancer diagnostics is transforming how healthcare organizations detect, analyze, and treat malignancies. This report highlights current market direction for AI-driven oncology diagnostics, with a focus on actionable insights for senior leaders navigating disruption in clinical workflows, procurement, and strategic partnerships.

Market Snapshot: AI in Cancer Diagnostics Market

The AI in Cancer Diagnostics Market grew from USD 266.28 million in 2024 to USD 326.78 million in 2025. It is expected to continue its strong expansion at a compound annual growth rate (CAGR) of 21.68%, reaching USD 864.46 million by 2030.

Scope & Segmentation

  • Application Areas: Diagnostic imaging (CT, MRI, PET, ultrasound), genomic profiling (DNA sequencing, epigenetic analysis, RNA sequencing), pathology (digital and histopathology), predictive analytics (outcome prediction, risk assessment), and treatment planning (radiotherapy, surgical planning).
  • Component Types: Hardware, managed services, professional services, cloud-based software, on-premises software.
  • End Users: Diagnostic laboratories, hospitals and clinics, pharmaceutical companies, research institutes.
  • Cancer Types: Breast, colorectal, lung, and prostate cancers.
  • Technologies: Deep learning, machine learning, natural language processing.
  • Regional Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, and other major countries), Asia-Pacific (China, India, Japan, Australia, Southeast Asia).
  • Leading Companies: Siemens Healthineers AG, GE HealthCare Technologies Inc, Koninklijke Philips N.V., Fujifilm Holdings Corporation, IBM, Roche Diagnostics International AG, Thermo Fisher Scientific Inc., QIAGEN N.V., Agilent Technologies, Hologic, and more.

Key Takeaways for Decision Makers

  • AI adoption is accelerating diagnostic accuracy and reducing interpretation variability, which can lead to more consistent patient outcomes across institutions.
  • Integration of multimodal datasets—imaging, genomic, and clinical information—enables more tailored risk assessment and personalized treatment strategies within oncology practice.
  • The regulatory landscape is rapidly adapting, focusing on algorithm validation, post-market surveillance, and establishing continuous learning systems to ensure quality and safety.
  • Partnerships between industry, academia, and healthcare providers are instrumental in standardizing data formats and facilitating successful algorithm validation across regions.
  • Emerging solutions in digital pathology and predictive analytics are supporting higher throughput, operational efficiencies, and broader access to advanced diagnostics, particularly in resource-constrained environments.

Tariff Impact: US Tariffs on AI Diagnostic Technologies

New United States tariffs introduced in 2025 for AI-based diagnostic technologies are increasing equipment and software supply chain costs. Manufacturers and providers are reevaluating sourcing and local production strategies, and cloud platform vendors are reassessing regional infrastructure and licensing, prompting localized solutions and new joint ventures. These adjustments aim to maintain momentum in AI-driven cancer diagnostics and manage budget constraints without delaying technology access or innovation.

Methodology & Data Sources

This report is built on primary interviews with clinicians, data scientists, and industry executives, paired with comprehensive secondary research of journals, white papers, and market data. Company disclosures, patent databases, and expert insights were rigorously cross-validated to ensure accuracy of segmentation and trend analysis.

Why This Report Matters

  • Provides a clear, actionable landscape view for senior leaders managing investments or procurement decisions in AI-enabled cancer diagnostics.
  • Enables in-depth benchmarking of competitive positioning, recent innovations, and partnership opportunities within a rapidly evolving marketplace.
  • Identifies crucial regulatory and operational considerations to inform supply chain, clinical integration, and compliance planning.

Conclusion

AI in cancer diagnostics is set to redefine clinical pathways, driven by innovation and data integration across the industry. Strategic leadership and cross-sector collaboration will shape future adoption patterns and operational best practices. Stakeholders equipped with the right insights can confidently advance diagnostic excellence and competitive strength in this evolving landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. AI in Cancer Diagnostics Market, by Application
8.1. Introduction
8.2. Diagnostic Imaging
8.2.1. CT Imaging
8.2.2. MRI Imaging
8.2.3. PET Imaging
8.2.4. Ultrasound Imaging
8.3. Genomic Profiling
8.3.1. DNA Sequencing
8.3.2. Epigenetic Analysis
8.3.3. RNA Sequencing
8.4. Pathology
8.4.1. Digital Pathology
8.4.2. Histopathology
8.5. Predictive Analytics
8.5.1. Outcome Prediction
8.5.2. Risk Assessment
8.6. Treatment Planning
8.6.1. Radiotherapy Planning
8.6.2. Surgical Planning
9. AI in Cancer Diagnostics Market, by Component
9.1. Introduction
9.2. Hardware
9.3. Services
9.3.1. Managed Services
9.3.2. Professional Services
9.4. Software
9.4.1. Cloud Based
9.4.2. On Premises
10. AI in Cancer Diagnostics Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Hospitals And Clinics
10.4. Pharmaceutical Companies
10.5. Research Institutes
11. AI in Cancer Diagnostics Market, by Cancer Type
11.1. Introduction
11.2. Breast Cancer
11.3. Colorectal Cancer
11.4. Lung Cancer
11.5. Prostate Cancer
12. AI in Cancer Diagnostics Market, by Technology
12.1. Introduction
12.2. Deep Learning
12.3. Machine Learning
12.4. Natural Language Processing
13. Americas AI in Cancer Diagnostics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa AI in Cancer Diagnostics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific AI in Cancer Diagnostics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Siemens Healthineers AG
16.3.2. GE HealthCare Technologies Inc
16.3.3. Koninklijke Philips N.V.
16.3.4. Fujifilm Holdings Corporation
16.3.5. International Business Machines Corporation
16.3.6. Roche Diagnostics International AG
16.3.7. Thermo Fisher Scientific Inc.
16.3.8. QIAGEN N.V.
16.3.9. Agilent Technologies, Inc.
16.3.10. Hologic, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. AI IN CANCER DIAGNOSTICS MARKET MULTI-CURRENCY
FIGURE 2. AI IN CANCER DIAGNOSTICS MARKET MULTI-LANGUAGE
FIGURE 3. AI IN CANCER DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. AI IN CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. AI IN CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. AI IN CANCER DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CT IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY MRI IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PET IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY EPIGENETIC ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY OUTCOME PREDICTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RADIOTHERAPY PLANNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SURGICAL PLANNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY MANAGED SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PROFESSIONAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CLOUD BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY ON PREMISES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 80. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 82. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 83. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 84. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 85. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 86. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 87. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 88. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 89. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 91. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 94. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 95. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 96. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 97. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 98. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 99. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 100. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 101. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 103. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 155. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 156. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 157. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 158. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 159. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 160. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 161. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 162. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 164. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. FRANCE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. FRANCE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 167. FRANCE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 168. FRANCE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 169. FRANCE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 170. FRANCE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 171. FRANCE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 172. FRANCE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 173. FRANCE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 174. FRANCE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. FRANCE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 176. FRANCE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 184. RUSSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. ITALY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. ITALY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 191. ITALY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 192. ITALY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 193. ITALY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 194. ITALY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 195. ITALY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 196. ITALY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 197. ITALY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 198. ITALY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. ITALY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 200. ITALY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. SPAIN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. SPAIN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 203. SPAIN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 204. SPAIN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 205. SPAIN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 206. SPAIN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 207. SPAIN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 208. SPAIN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 209. SPAIN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 210. SPAIN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. SPAIN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 212. SPAIN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. SAUDI ARABIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 249. DENMARK AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. DENMARK AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 251. DENMARK AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 252. DENMARK AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 253. DENMARK AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 254. DENMARK AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 255. DENMARK AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 256. DENMARK AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 257. DENMARK AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 258. DENMARK AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. DENMARK AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 260. DENMARK AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 270. NETHERLANDS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. NETHERLANDS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 272. NETHERLANDS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 273. QATAR AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. QATAR AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 275. QATAR AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 276. QATAR AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 277. QATAR AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 278. QATAR AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 279. QATAR AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 280. QATAR AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 281. QATAR AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 282. QATAR AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. QATAR AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 284. QATAR AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 285. FINLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. FINLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 287. FINLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 288. FINLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 289. FINLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 290. FINLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 291. FINLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 292. FINLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 293. FINLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 294. FINLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. FINLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 296. FINLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 304. SWEDEN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 305. SWEDEN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 306. SWEDEN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. SWEDEN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 308. SWEDEN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 309. NIGERIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 311. NIGERIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 312. NIGERIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 313. NIGERIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2030 (USD MILLION)
TABLE 314. NIGERIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TREATMENT PLANNING, 2018-2030 (USD MILLION)
TABLE 315. NIGERIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 316. NIGERIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 317. NIGERIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 318. NIGERIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. NIGERIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 320. NIGERIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 321. EGYPT AI IN CANCER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 322. EGYPT AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 323. EGYPT AI IN CANCER DIAGNOSTICS MARKET SIZE, BY GENOMIC PROFILING, 2018-2030 (USD MILLION)
TABLE 324. EGYPT AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 325. EGYPT AI IN CANCER DIAGNOSTICS

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this AI in Cancer Diagnostics market report include:
  • Siemens Healthineers AG
  • GE HealthCare Technologies Inc
  • Koninklijke Philips N.V.
  • Fujifilm Holdings Corporation
  • International Business Machines Corporation
  • Roche Diagnostics International AG
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • Hologic, Inc.

Table Information

Report AttributeDetails
No. of Pages192
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 326.78 Million
Forecasted Market Value ( USD ) by 2030 $ 864.46 Million
Compound Annual Growth Rate21.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Brain Cancer Diagnostics Market by Technology, Product, Indication, Distribution Channel, End User - Global Forecast to 2030 - Product Image

Brain Cancer Diagnostics Market by Technology, Product, Indication, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
Next-Generation Breast Cancer Diagnostic & Screening Market by Offerings, Test Type, Stage, Application, End User - Global Forecast to 2030 - Product Image

Next-Generation Breast Cancer Diagnostic & Screening Market by Offerings, Test Type, Stage, Application, End User - Global Forecast to 2030

  • Report
  • 187 Pages
  • Global
From
Gastric Cancer Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Gastric Cancer Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Breast Cancer Diagnostics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Breast Cancer Diagnostics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 88 Pages
  • Global
From
AI In Cancer Diagnostics Market Size, Share & Trends Analysis Report By Component (Software Solutions, Hardware, Services), By Cancer Type, By End-use (Hospitals, Surgical Centers and Medical Institutes), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

AI In Cancer Diagnostics Market Size, Share & Trends Analysis Report By Component (Software Solutions, Hardware, Services), By Cancer Type, By End-use (Hospitals, Surgical Centers and Medical Institutes), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.